CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 125 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $30,000 | -18.9% | 5,922 | 0.0% | 0.00% | – |
| Q2 2021 | $37,000 | -19.6% | 5,922 | 0.0% | 0.00% | – |
| Q1 2021 | $46,000 | +17.9% | 5,922 | 0.0% | 0.00% | – |
| Q4 2020 | $39,000 | 0.0% | 5,922 | 0.0% | 0.00% | – |
| Q3 2020 | $39,000 | -20.4% | 5,922 | 0.0% | 0.00% | – |
| Q2 2020 | $49,000 | +157.9% | 5,922 | +141.4% | 0.00% | – |
| Q1 2020 | $19,000 | -5.0% | 2,453 | 0.0% | 0.00% | – |
| Q4 2019 | $20,000 | +11.1% | 2,453 | 0.0% | 0.00% | – |
| Q3 2019 | $18,000 | -35.7% | 2,453 | 0.0% | 0.00% | – |
| Q2 2019 | $28,000 | +7.7% | 2,453 | 0.0% | 0.00% | – |
| Q1 2019 | $26,000 | -29.7% | 2,453 | 0.0% | 0.00% | – |
| Q4 2018 | $37,000 | -17.8% | 2,453 | 0.0% | 0.00% | – |
| Q3 2018 | $45,000 | -19.6% | 2,453 | 0.0% | 0.00% | – |
| Q2 2018 | $56,000 | -40.4% | 2,453 | -25.5% | 0.00% | -100.0% |
| Q1 2018 | $94,000 | +36.2% | 3,291 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $69,000 | – | 3,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
| Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
| Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
| RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
| Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
| Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
| WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |